Selected research
Industry Research
Compound Contraceptive Pills Industry Research Report 2026
Market perspective
The global Compound Contraceptive Pills market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Compound Contraceptive Pills is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Compound Contraceptive Pills is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Compound Contraceptive Pills is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Compound Contraceptive Pills include Sine Tianping Pharmaceutical, Zhejiang Xianju Pharmaceutical, Teva Pharmaceuticals, Sandoz, Humanwell Healthcare, Johnson And Johnson, Mylan, Roche and Langsen Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Compound Contraceptive Pills market in terms of revenue (US$ million) and, where applicable, sales volume (units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Compound Contraceptive Pills Market by Company
Sine Tianping Pharmaceutical
Zhejiang Xianju Pharmaceutical
Teva Pharmaceuticals
Sandoz
Humanwell Healthcare
Johnson And Johnson
Mylan
Roche
Langsen Pharmaceutical
Pfizer
China Resources Zizhu Pharmaceutical
Hisun Pharmaceutical
Bayer
Lupin Pharmaceuticals
HRA Pharma
Compound Contraceptive Pills Segment by Type
Long Acting Contraceptive Pills
New Compound Preparation
Emergency Contraceptive Pills
Short Acting Contraceptive Pills
Compound Contraceptive Pills Segment by Application
Menstrual Cycle Regulation
Dysmenorrhea Treatment
Hormonal Replacement Therapy
Menopausal Symptoms Relieved
Contraception
Others
Compound Contraceptive Pills Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Compound Contraceptive Pills market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Compound Contraceptive Pills and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Compound Contraceptive Pills.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Compound Contraceptive Pills manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Compound Contraceptive Pills by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Compound Contraceptive Pills in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Long Acting Contraceptive Pills
- New Compound Preparation
- Emergency Contraceptive Pills
- Short Acting Contraceptive Pills
Applications
- Menstrual Cycle Regulation
- Dysmenorrhea Treatment
- Hormonal Replacement Therapy
- Menopausal Symptoms Relieved
- Contraception
- Others
Companies covered
- Sine Tianping Pharmaceutical
- Zhejiang Xianju Pharmaceutical
- Teva Pharmaceuticals
- Sandoz
- Humanwell Healthcare
- Johnson And Johnson
- Mylan
- Roche
- Langsen Pharmaceutical
- Pfizer
- China Resources Zizhu Pharmaceutical
- Hisun Pharmaceutical
- Bayer
- Lupin Pharmaceuticals
- HRA Pharma
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Compound Contraceptive Pills Market Size (2021-2032)
- 2.2.2 Global Compound Contraceptive Pills Sales (2021-2032)
- 2.2.3 Global Compound Contraceptive Pills Market Average Price (2021-2032)
- 2.3 Compound Contraceptive Pills by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Long Acting Contraceptive Pills
- 2.3.3 New Compound Preparation
- 2.3.4 Emergency Contraceptive Pills
- 2.3.5 Short Acting Contraceptive Pills
- 2.4 Compound Contraceptive Pills by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Menstrual Cycle Regulation
- 2.4.3 Dysmenorrhea Treatment
- 2.4.4 Hormonal Replacement Therapy
- 2.4.5 Menopausal Symptoms Relieved
- 2.4.6 Contraception
- 2.4.7 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Compound Contraceptive Pills Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Compound Contraceptive Pills Sales (units) of Manufacturers (2021-2026)
- 3.3 Global Compound Contraceptive Pills Revenue of Manufacturers (2021-2026)
- 3.4 Global Compound Contraceptive Pills Average Price by Manufacturers (2021-2026)
- 3.5 Global Compound Contraceptive Pills Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Compound Contraceptive Pills, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Compound Contraceptive Pills, Product Type & Application
- 3.8 Global Manufacturers of Compound Contraceptive Pills, Established Date
- 3.9 Global Compound Contraceptive Pills Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Sine Tianping Pharmaceutical
- 4.1.1 Sine Tianping Pharmaceutical Company Information
- 4.1.2 Sine Tianping Pharmaceutical Business Overview
- 4.1.3 Sine Tianping Pharmaceutical Compound Contraceptive Pills Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Sine Tianping Pharmaceutical Compound Contraceptive Pills Product Portfolio
- 4.1.5 Sine Tianping Pharmaceutical Recent Developments
- 4.2 Zhejiang Xianju Pharmaceutical
- 4.2.1 Zhejiang Xianju Pharmaceutical Company Information
- 4.2.2 Zhejiang Xianju Pharmaceutical Business Overview
- 4.2.3 Zhejiang Xianju Pharmaceutical Compound Contraceptive Pills Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Zhejiang Xianju Pharmaceutical Compound Contraceptive Pills Product Portfolio
- 4.2.5 Zhejiang Xianju Pharmaceutical Recent Developments
- 4.3 Teva Pharmaceuticals
- 4.3.1 Teva Pharmaceuticals Company Information
- 4.3.2 Teva Pharmaceuticals Business Overview
- 4.3.3 Teva Pharmaceuticals Compound Contraceptive Pills Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Teva Pharmaceuticals Compound Contraceptive Pills Product Portfolio
- 4.3.5 Teva Pharmaceuticals Recent Developments
- 4.4 Sandoz
- 4.4.1 Sandoz Company Information
- 4.4.2 Sandoz Business Overview
- 4.4.3 Sandoz Compound Contraceptive Pills Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Sandoz Compound Contraceptive Pills Product Portfolio
- 4.4.5 Sandoz Recent Developments
- 4.5 Humanwell Healthcare
- 4.5.1 Humanwell Healthcare Company Information
- 4.5.2 Humanwell Healthcare Business Overview
- 4.5.3 Humanwell Healthcare Compound Contraceptive Pills Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Humanwell Healthcare Compound Contraceptive Pills Product Portfolio
- 4.5.5 Humanwell Healthcare Recent Developments
- 4.6 Johnson And Johnson
- 4.6.1 Johnson And Johnson Company Information
- 4.6.2 Johnson And Johnson Business Overview
- 4.6.3 Johnson And Johnson Compound Contraceptive Pills Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Johnson And Johnson Compound Contraceptive Pills Product Portfolio
- 4.6.5 Johnson And Johnson Recent Developments
- 4.7 Mylan
- 4.7.1 Mylan Company Information
- 4.7.2 Mylan Business Overview
- 4.7.3 Mylan Compound Contraceptive Pills Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Mylan Compound Contraceptive Pills Product Portfolio
- 4.7.5 Mylan Recent Developments
- 4.8 Roche
- 4.8.1 Roche Company Information
- 4.8.2 Roche Business Overview
- 4.8.3 Roche Compound Contraceptive Pills Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Roche Compound Contraceptive Pills Product Portfolio
- 4.8.5 Roche Recent Developments
- 4.9 Langsen Pharmaceutical
- 4.9.1 Langsen Pharmaceutical Company Information
- 4.9.2 Langsen Pharmaceutical Business Overview
- 4.9.3 Langsen Pharmaceutical Compound Contraceptive Pills Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Langsen Pharmaceutical Compound Contraceptive Pills Product Portfolio
- 4.9.5 Langsen Pharmaceutical Recent Developments
- 4.10 Pfizer
- 4.10.1 Pfizer Company Information
- 4.10.2 Pfizer Business Overview
- 4.10.3 Pfizer Compound Contraceptive Pills Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Pfizer Compound Contraceptive Pills Product Portfolio
- 4.10.5 Pfizer Recent Developments
- 4.11 China Resources Zizhu Pharmaceutical
- 4.11.1 China Resources Zizhu Pharmaceutical Company Information
- 4.11.2 China Resources Zizhu Pharmaceutical Business Overview
- 4.11.3 China Resources Zizhu Pharmaceutical Compound Contraceptive Pills Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 China Resources Zizhu Pharmaceutical Compound Contraceptive Pills Product Portfolio
- 4.11.5 China Resources Zizhu Pharmaceutical Recent Developments
- 4.12 Hisun Pharmaceutical
- 4.12.1 Hisun Pharmaceutical Company Information
- 4.12.2 Hisun Pharmaceutical Business Overview
- 4.12.3 Hisun Pharmaceutical Compound Contraceptive Pills Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Hisun Pharmaceutical Compound Contraceptive Pills Product Portfolio
- 4.12.5 Hisun Pharmaceutical Recent Developments
- 4.13 Bayer
- 4.13.1 Bayer Company Information
- 4.13.2 Bayer Business Overview
- 4.13.3 Bayer Compound Contraceptive Pills Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Bayer Compound Contraceptive Pills Product Portfolio
- 4.13.5 Bayer Recent Developments
- 4.14 Lupin Pharmaceuticals
- 4.14.1 Lupin Pharmaceuticals Company Information
- 4.14.2 Lupin Pharmaceuticals Business Overview
- 4.14.3 Lupin Pharmaceuticals Compound Contraceptive Pills Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Lupin Pharmaceuticals Compound Contraceptive Pills Product Portfolio
- 4.14.5 Lupin Pharmaceuticals Recent Developments
- 4.15 HRA Pharma
- 4.15.1 HRA Pharma Company Information
- 4.15.2 HRA Pharma Business Overview
- 4.15.3 HRA Pharma Compound Contraceptive Pills Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 HRA Pharma Compound Contraceptive Pills Product Portfolio
- 4.15.5 HRA Pharma Recent Developments
5 Global Compound Contraceptive Pills Market Scenario by Region
- 5.1 Global Compound Contraceptive Pills Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Compound Contraceptive Pills Sales by Region: 2021-2032
- 5.2.1 Global Compound Contraceptive Pills Sales by Region: 2021-2026
- 5.2.2 Global Compound Contraceptive Pills Sales by Region: 2027-2032
- 5.3 Global Compound Contraceptive Pills Revenue by Region: 2021-2032
- 5.3.1 Global Compound Contraceptive Pills Revenue by Region: 2021-2026
- 5.3.2 Global Compound Contraceptive Pills Revenue by Region: 2027-2032
- 5.4 North America Compound Contraceptive Pills Market Facts & Figures by Country
- 5.4.1 North America Compound Contraceptive Pills Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Compound Contraceptive Pills Sales by Country (2021-2032)
- 5.4.3 North America Compound Contraceptive Pills Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Compound Contraceptive Pills Market Facts & Figures by Country
- 5.5.1 Europe Compound Contraceptive Pills Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Compound Contraceptive Pills Sales by Country (2021-2032)
- 5.5.3 Europe Compound Contraceptive Pills Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Compound Contraceptive Pills Market Facts & Figures by Country
- 5.6.1 Asia Pacific Compound Contraceptive Pills Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Compound Contraceptive Pills Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Compound Contraceptive Pills Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Compound Contraceptive Pills Market Facts & Figures by Country
- 5.7.1 South America Compound Contraceptive Pills Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Compound Contraceptive Pills Sales by Country (2021-2032)
- 5.7.3 South America Compound Contraceptive Pills Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Compound Contraceptive Pills Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Compound Contraceptive Pills Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Compound Contraceptive Pills Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Compound Contraceptive Pills Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Compound Contraceptive Pills Sales by Type (2021-2032)
- 6.1.1 Global Compound Contraceptive Pills Sales by Type (2021-2032) & (units)
- 6.1.2 Global Compound Contraceptive Pills Sales Market Share by Type (2021-2032)
- 6.2 Global Compound Contraceptive Pills Revenue by Type (2021-2032)
- 6.2.1 Global Compound Contraceptive Pills Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Compound Contraceptive Pills Revenue Market Share by Type (2021-2032)
- 6.3 Global Compound Contraceptive Pills Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Compound Contraceptive Pills Sales by Application (2021-2032)
- 7.1.1 Global Compound Contraceptive Pills Sales by Application (2021-2032) & (units)
- 7.1.2 Global Compound Contraceptive Pills Sales Market Share by Application (2021-2032)
- 7.2 Global Compound Contraceptive Pills Revenue by Application (2021-2032)
- 7.2.1 Global Compound Contraceptive Pills Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Compound Contraceptive Pills Revenue Market Share by Application (2021-2032)
- 7.3 Global Compound Contraceptive Pills Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Compound Contraceptive Pills Value Chain Analysis
- 8.1.1 Compound Contraceptive Pills Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Compound Contraceptive Pills Production Mode & Process
- 8.2 Compound Contraceptive Pills Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Compound Contraceptive Pills Distributors
- 8.2.3 Compound Contraceptive Pills Customers
9 Global Compound Contraceptive Pills Analyzing Market Dynamics
- 9.1 Compound Contraceptive Pills Industry Trends
- 9.2 Compound Contraceptive Pills Industry Drivers
- 9.3 Compound Contraceptive Pills Industry Opportunities and Challenges
- 9.4 Compound Contraceptive Pills Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst